secwatch.observer — SEC 8-K summary
======================================

Issuer:     SS Innovations International, Inc. (SSII)
CIK:        0001676163
Form:       8-K
Filed at:   2025-10-03T23:59:59+00:00
Accession:  0001213900-25-095851
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SS Innovations completes human factors validation study for SSi Mantra; plans FDA 510(k) in Q4 2025
--------------------------------------------------------------------------------

- Completed human factors validation study for SSi Mantra surgical robotic system at Johns Hopkins Hospital in September 2025.
- Anticipates submitting 510(k) premarket notification to FDA in Q4 2025; potential US clearance in H1 2026 if FDA approves.
- Company pivoted from De Novo request to 510(k) pathway for speed and cost advantages per FDA discussions.
- SSi Mantra cumulative installed base: 125 systems across 6 countries; 119 hospitals, over 6,000 procedures performed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676163/000121390025095851/0001213900-25-095851-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676163/000121390025095851/ea0260185-8k_ssinnova.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-095851

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer